Abstract
Purpose
Oral mucositis is a common symptomatic complication associated with hematopoietic stem cell transplantation (HCT). We use simple strategies aimed to reduce oral mucositis by keeping the oral cavity clean and moist. Here, we report on the progress of oral care and the changes in the degree of oral mucositis. The purpose of this pilot study is to evaluate the effects of our strategies on the prevalence and the severity of oral mucositis.
Methods
Fifty-three consecutive patients from 2003 to 2006 administered with conventional allogeneic HCT were enrolled in this study. The degree of oral mucositis was evaluated daily in all patients. Our oral care program was divided into two periods: “examination and trial period (2003 and 2004)” and “intensive oral care period (2005 and 2006).” In the latter, an oral care regimen was carried out systematically by a multidisciplinary team.
Results
Using our oral care strategies, the prevalence of ulcerative oral mucositis was decreased significantly. The rate was reduced from 76% (10 of 13) of patients with ulcerative oral mucositis in 2003 to only 20% (3 of 15) in 2006.
Conclusions
Our pilot study suggests that oral mucositis in HCT patients can be alleviated by simple strategies aimed at keeping the oral cavity clean and moist.
References
Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4:227–284
Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205
Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33–39
Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831
Bensinger W, Schubert M, Ang KK, Brizel D, Brown E, Eilers JG, Elting L, Mittal BB, Schattner MA, Spielberger R, Treister NS, Trotti AM 3rd (2008) NCCN task force report. Prevention and management of mucositis in cancer care. J Natl Compr Canc Netw 6(Suppl 1):S1–S21
Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730
US National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.ppd. Accessed 4 January 2010
Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M (1994) Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 30B:93–97
Sugiura Y, Soga Y, Tanimoto I, Kokeguchi S, Nishide S, Kono K, Takahashi K, Fujii N, Ishimaru F, Tanimoto M, Yamabe K, Tsutani S, Nishimura F, Takashiba S (2008) Antimicrobial effects of the saliva substitute, Oralbalance, against microorganisms from oral mucosa in the hematopoietic cell transplantation period. Support Care Cancer 16:421–424
Ransier A, Epstein JB, Lunn R, Spinelli J (1995) A combined analysis of a toothbrush, foam brush, and a chlorhexidine-soaked foam brush in maintaining oral hygiene. Cancer Nurs 18:393–396
Acknowledgments
This study was partially conducted as the education curriculum, Practice in Dental Sciences, in Okayama University Dental School. We thank Ms. Yuka Oka, a student at Okayama University Dental School, for data analysis.
This study was partly supported by a Grant-in-Aid for Young Scientists (Start-up #20890138 and B #22791836 to YS) from the Japan Society for the Promotion of Science and an unrestricted grant from the Scholarship Fund donated by the T&K Corporation, Tokyo, Japan (to ST). T&K Corporation is the exclusive agent of Biotene® products, including Oralbalance® (Laclede, Rancho Dominguez, CA), in Japan. Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences approved this private scholarship fund.
Conflicts of Interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Soga, Y., Sugiura, Y., Takahashi, K. et al. Progress of oral care and reduction of oral mucositis—a pilot study in a hematopoietic stem cell transplantation ward. Support Care Cancer 19, 303–307 (2011). https://doi.org/10.1007/s00520-010-1002-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-010-1002-y